HLA PHENOTYPE AND CLINICOPATHOLOGICAL BEHAVIOR OF GERM-CELL TUMORS - POSSIBLE EVIDENCE FOR CLONAL EVOLUTION FROM SEMINOMAS TO NONSEMINOMAS

被引：34

作者：

OLIVER, RTD

机构：

[1] ST BARTHOLOMEWS MED COLL,LONDON EC1A 7BE,ENGLAND

[2] INST UROL,LONDON,ENGLAND

来源：

INTERNATIONAL JOURNAL OF ANDROLOGY | 1987年 / 10卷 / 01期

关键词：

D O I：

10.1111/j.1365-2605.1987.tb00169.x

中图分类号：

R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

摘要：

引用

页码：85 / 93

页数：9

共 20 条

[1]

AIGINGER P, 1983, P AM ASSOC CANC RES, V24, P190

[2] PROGNOSTIC SIGNIFICANCE OF MODAL DNA VALUE AND OTHER FACTORS IN MALIGNANT-TUMORS, BASED ON 1465 CASES [J].

ATKIN, NB ;

KAY, R .

BRITISH JOURNAL OF CANCER, 1979, 40 (02) :210-221

[3] HLA AND TESTICULAR CANCER [J].

DEWOLF, WC ;

LANGE, PH ;

EINARSON, ME ;

YUNIS, EJ .

NATURE, 1979, 277 (5693) :216-217

[4] TUMOR IMMUNOLOGY - MOLECULAR-BASIS OF TUMOR SPREAD [J].

HART, IR .

NATURE, 1985, 315 (6017) :274-274

[5]

HORS J, 1984, HISTOCOMPATIBILITY T, P411

[6] REJECTION OF TRANSPLANTABLE AKR LEUKEMIA-CELLS FOLLOWING MHC DNA-MEDIATED CELL-TRANSFORMATION [J].

HUI, K ;

GROSVELD, F ;

FESTENSTEIN, H .

NATURE, 1984, 311 (5988) :750-752

[7]

Lilly F., 1973, Advances in Cancer Research, V17, P231, DOI 10.1016/S0065-230X(08)60532-1

[8]

MOSTOFI FK, 1984, PROGR CONTROVERSIES, P69

[9]

MULLER J, 1981, INT J ANDROL S, V4, P211

[10]

OLIVER RTD, 1986, LANCET, V1, P1506

← 1 2 →